GE To Enter China’s Medical Home Care Market
This article was originally published in PharmAsia News
Executive Summary
GE Healthcare has announced it will introduce home respiratory and sleep care solutions into China's homes. The Vivo series of electronic ventilators and non-invasive iSleep devices used for home respiratory support and sleep apnea come from Vital Signs and its subsidiary Breas Medical, which were acquired by GE a few years ago. The move represents the firm's first foray into the country's medical home care market, giving it direct access to patients. GE Healthcare sees home health care as an emerging sector with rapid growth and China offers huge market potential. (Click here for more - Chinese Language)
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.